Clinical and molecular risk factors which correlate with prognosis include age at diagnosis, stage, histology, chromosomal aberrations, and amplification of the N-myc proto-oncogene (MYCN), which is the most typical genetic feature of advanced-stage neuroblastoma [3,5,6]. The gene discussed is MYCN; the disease is neuroblastoma.